Skip to content
← Holders

Hikari Power Ltd

What Hikari Power Ltd reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1606152 · Filed Oct 30, 2026

Positions
36
Reported value
$438.6K
Opened
2
Closed
9
Other managers included
1

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$1.2M
    63 positions
  2. Dec 31, 2025$1.3M
    63 positions
  3. Mar 31, 2026$1.1M
    51 positions
  4. Jun 30, 2026$854.5K
    43 positions
  5. Sep 30, 2026$438.6K
    36 positions
SecuritySharesChangeValueOf portfolio
BERKSHIRE HATHAWAY INC CLASS ACL A
458−33.9%$342.1K78%
GOOGAlphabet Inc.
46.5K−58.1%$15.8K3.6%
VANGUARD ULTRA SHORT TREASURY ETFETF
137K±0%$10.4K2.4%
VVisa Inc.
25.3K−79.7%$9.1K2.1%
PSXPhillips 66
34K−78.1%$8.7K2%
XOMExxonMobil Holdings Corp
52.5K−79.2%$8.5K1.9%
DHRDanaher Corp
20.5K±0%$4.5K1%
VANGUARD ULTRA SHORT BOND ETFETF
90.6K±0%$4.5K1%
ROPRoper Technologies Inc
12K−80.0%$4.2K1%
BERKSHIRE HATHAWAY INC CLASS BCL B
7.7K±0%$3.8K0.9%
MCOMoody's Corp
8.2K−74.5%$3.7K0.9%
BNYBank of New York Mellon Corp
23.9K−80.0%$3.5K0.8%
GOOGLAlphabet Inc.
7K−2.8%$2.4K0.5%
JNJJohnson & Johnson
8.1K−94.9%$2.1K0.5%
NTRNutrien Ltd.
30K−80.0%$2.1K0.5%
WATWaters Corp
4K−15.7%$1.8K0.4%
SHELShell plc
18K−15.9%$1.7K0.4%
WABWestinghouse Air Brake Technologies Corp
5.7K−7.7%$1.6K0.4%
ISRGIntuitive Surgical Inc
2.6K−81.4%$1.1K0.2%
AMEAMETEK Inc
3.9K±0%$9760.2%
ZTSZoetis Inc.
11.7K+33.0%$8160.2%
AMGNAmgen Inc
1.9K−78.7%$8010.2%
AAgilent Technologies, Inc.
3.4K±0%$5810.1%
CRVSCorvus Pharmaceuticals, Inc.
50K±0%$5760.1%
VEEVVeeva Systems Inc
2K−12.3%$5710.1%
NVONovo Nordisk a S
11.3K−80.1%$4280.1%
MTDMettler Toledo International Inc
235±0%$3550.1%
LMTLockheed Martin Corp
690±0%$3510.1%
TGTXTG Therapeutics, Inc.
5K±0%$2790.1%
VANGUARD HEALTH CARE ETFETF
840±0%$2660.1%
BNBrookfield Corp
6.2K±0%$2240.1%
KOCoca Cola Co
2.4KNew$2070.1%
AVXLAnavex Life Sciences Corp.
85.6K±0%$1730.1%
OCULOcular Therapeutix, Inc
17K±0%$1300.1%
SABRSabre Corp
61KNew$1290.1%
ALDXAldeyra Therapeutics, Inc.
20K±0%$250.1%